Kenneth R. Brouwer, Ph.D., RPh.

Kenneth Brouwer is a seasoned professional with extensive experience in research and development within the pharmaceutical industry. Currently serving as Global Research Liaison at BioIVT since January 2018, Kenneth has previously held prominent positions such as Vice President of Technology ADME-TOX at Qualyst Transporter Solutions, LLC from January 2003 to January 2018, and Chief Scientific Officer at PPD from January 2002 to January 2003. Kenneth's foundational experience includes roles as Director of PreClinical Development and Senior Scientist in Drug Metabolism at GlaxoSmithKline from January 1986 to January 2002. Academic credentials include a Ph.D. in Pharmacokinetics/Drug Metabolism from the University of Kentucky and a degree in Organizational Change Leadership from American University.